BIOR Projected Dividend Yield
Biora Therapeutics Inc ( NASDAQ : BIOR )Biora Therapeutics is a biotechnology company developing oral biotherapeutics. Co.'s therapeutics pipeline includes two therapeutic delivery platforms: NAVICAP™ Targeted Oral Delivery Platform and BIOJET™ Systemic Oral Delivery Platform. Co.'s Targeted Therapeutics program includes BT-600, an orally delivered liquid formulation of tofacitinib for the treatment of ulcerative colitis. Co.'s Systemic Therapeutics program includes BT-002, a combination product of a variant of adalimumab and the BIOJET device for the treatment of inflammatory conditions; as well as BT-200, a combination product of a GLP-1 receptor agonist and the BIOJET device for the treatment of type 2 diabetes. 20 YEAR PERFORMANCE RESULTS |
BIOR Dividend History Detail BIOR Dividend News BIOR Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |